Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2Phase 3 Interventional

Protective Effects of Propranolol in Adults

ClinicalTrials.gov ID: NCT01902810

Public ClinicalTrials.gov record NCT01902810. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 1:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Protective Effects of Propranolol in Adults Following Major Burn Injury: A Safety and Efficacy Trial

Study identification

NCT ID
NCT01902810
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
The University of Texas Medical Branch, Galveston
Other
Enrollment
47 participants

Conditions and interventions

Conditions

Interventions

  • Propranolol Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2013
Primary completion
May 31, 2019
Completion
Jul 11, 2019
Last update posted
Nov 28, 2019

2013 – 2019

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
University of Florida Gainesville Florida 32610
Loyola University Burn Center Maywood Illinois 60153
University of Iowa Iowa City Iowa 52242
Massachusetts General Hospital Boston Massachusetts 02114
Cornell Burn Center New York New York 10065
Ohio State University Columbus Ohio 43210
University of Texas, Southwestern Dallas Texas 75390
University of Texas Medical Branch Galveston Texas 77551
University of Washington Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01902810, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 28, 2019 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01902810 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →